The USFDA granted JB Chemicals approval for its new drug application, Amitriptyline Hydrochloride Tablets United States ...

Since the COVID-19 pandemic, levels of clinically elevated depression and anxiety symptoms in children have skyrocketed ...

Depression in children, just like adults, is a far cry from "I am having a bad day", and causes persistent sadness or ...

Israel knows how to prepare for war. It’s time we learn how to prepare for what comes after — a mental health crisis that ...

Many of us feel sluggish or less social when it’s colder. But seasonal affective disorder is more than just a slump.

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

University of California, San Diego researchers say CBD can help ease autism symptoms. In the first controlled clinical trial, doctors used CBD on boys with autism. Researchers say two-thirds showed ...

Although the company withheld detailed findings from the study of treatment-resistant depression, analysts at Stifel called ...

A single dose of a synthetic, proprietary formulation of psilocybin (COMP360) was found to improve symptoms in patients with treatment-resistant ...

Compass Pathways' psilocybin-based depression therapy reduced the severity of symptoms in a closely watched study, but shares of the biotech firm plunged more than 46% to a record low on Monday as the ...

Compass Pathways says a single dose of its synthetic psilocybin significantly reduced depression symptoms in patients who ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.